Results 51 to 60 of about 662,452 (292)

Dual disorders or dual diagnosis?

open access: yesIrish Journal of Psychological Medicine
Abstract “Dual disorders” (DD) refers to the co-occurrence of addiction and other mental health conditions, which often interact and complicate care. Despite scientific evidence showing shared brain mechanisms, current diagnostic systems treat them separately, leading to fragmented treatment and stigma.
Nestor Szerman, Lars Lien, Ruben Baler
openaire   +2 more sources

Efficacy and Safety Analysis of Roxarestat in Regulating Renal Anemia in Patients on Maintenance Hemodialysis

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Objective To compare the efficacy and safety of roxarestat versus recombinant human erythropoietin (rhEPO) in the management of renal anemia in patients undergoing maintenance hemodialysis. Methods This was a prospective, open‐label, randomized controlled trial.
Lingling Chen, Junjie Zhu, Qiaonan Ge
wiley   +1 more source

The relationship between personality dimensions and addiction type in women addicted to alcohol and opioids

open access: yesScientific Reports
Personality traits significantly influence the development, persistence, and treatment outcomes of substance use disorders. Despite increasing addiction rates among women, sex-specific research remains limited.
Diana Raketić   +4 more
doaj   +1 more source

Latent Impulsivity Subtypes in Substance Use Disorders and Interactions with Internalizing and Externalizing Co-Occurring Disorders

open access: yesFrontiers in Psychiatry, 2018
This study explored the clinical importance of latent impulsivity subtypes within a sample of individuals with substance use disorders (SUDs) and high rates of co-occurring disorders (CODs) receiving residential treatment, aiming to assess the ...
Rodrigo Marín-Navarrete   +8 more
doaj   +1 more source

Psychiatric comorbidity among patients attending an addiction treatment center in Morocco

open access: yesEuropean Psychiatry, 2022
Introduction The comorbidity between psychiatric disorders and substance use disorders is more and more common in daily clinical practice. However, only few studies have adressed this subject in north african patients.
A. Jelti   +4 more
doaj   +1 more source

The Health Status of New Medicaid Enrollees Under Health Reform [PDF]

open access: yes, 2010
Examines the demographic and health data of those newly eligible for Medicaid coverage, whether younger and healthier or older and less healthy than current enrollees, and how they will affect costs depending on participation ...
Genevieve M. Kenney   +2 more
core  

Therapeutic Apheresis for Intravenous Methylprednisolone‐Refractory Neuromyelitis Optica Spectrum Disorder: Clinical and Radiological Outcomes in a Single‐Center Case Series

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Neuromyelitis optica spectrum disorder (NMOSD) is a relapsing autoimmune disease of the central nervous system. High‐dose intravenous methylprednisolone (IVMP) is the standard first‐line therapy for acute attacks, although some patients remain refractory.
Wataru Horiguchi   +5 more
wiley   +1 more source

Investigating the Effectiveness of Brexpiprazole in Subjects with Schizophrenia Spectrum Illness and Co-Occurring Substance Use Disorder: A Prospective, Multicentric, Real-World Study

open access: yesPharmaceuticals
Background: Dual disorders (DDs) involve the coexistence of a substance use disorder (SUD) with another mental illness, often from the psychotic and affective categories.
Stefania Chiappini   +14 more
doaj   +1 more source

The cultural epigenetics of psychopathology: The missing heritability of complex diseases found? [PDF]

open access: yes, 2009
We extend a cognitive paradigm for gene expression based on the asymptotic limit theorems of information theory to the epigenetic epidemiology of mental disorders.
Wallace, Rodrick
core   +1 more source

Glucagon-like peptide analogues for type 2 diabetes mellitus : systematic review and meta-analysis [PDF]

open access: yes, 2010
Background Glucagon-like peptide (GLP-1) analogues are a new class of drugs used in the treatment of type 2 diabetes. They are given by injection, and regulate glucose levels by stimulating glucose-dependent insulin secretion and biosynthesis ...
Clar, C.   +4 more
core   +5 more sources

Home - About - Disclaimer - Privacy